Thyroid, Head and Neck Cancer (THANC) Foundation, 10 Union Square East, Suite 5B, New York, NY, 10003, USA.
Minkowitz Pathology, 904 49th Street, Brooklyn, NY, 11219, USA.
Diagn Pathol. 2023 Apr 18;18(1):47. doi: 10.1186/s13000-023-01336-6.
Struma ovarii is an unusual ovarian teratoma containing predominantly thyroid tissue. Less than 10% of cases undergo malignant transformation in the thyroid tissue and are considered malignant struma ovarii (MSO). MSO have been reported with concurrent thyroid lesions, but molecular data is lacking.
A 42-year-old female developed MSO and synchronous multifocal subcentimeter papillary thyroid carcinoma (PTC). The patient underwent a salpingo-oophrectomy, thyroidectomy, and low-dose radioactive iodine ablation. Both the thyroid subcentimeter PTC and MSO were positive for BRAF V600E mutation, and microRNA expression profiles were similar across all tumor deposits. However, only the malignant component demonstrated extensive loss of heterozygosity (LOH) involving multiple tumor suppressor gene (TSG) chromosomal loci.
We present the first reported case of MSO with synchronous multifocal subcentimeter PTC in the thyroid containing concordant BRAF V600E mutations and resulting with discordant LOH findings. This data suggests that loss of expression in tumor suppressor gene(s) may be an important contributor to phenotypic expression of malignancy.
卵巢甲状腺肿是一种不常见的卵巢畸胎瘤,主要含有甲状腺组织。不到 10%的病例在甲状腺组织中发生恶性转化,被认为是恶性卵巢甲状腺肿(MSO)。MSO 与同时存在的甲状腺病变有关,但缺乏分子数据。
一名 42 岁女性患有 MSO 和同步多发亚厘米大小的甲状腺乳头状癌(PTC)。患者接受了输卵管卵巢切除术、甲状腺切除术和低剂量放射性碘消融术。甲状腺亚厘米大小的 PTC 和 MSO 均为 BRAF V600E 突变阳性,所有肿瘤沉积物的 microRNA 表达谱相似。然而,只有恶性成分表现出广泛的杂合性丢失(LOH),涉及多个肿瘤抑制基因(TSG)染色体位点。
我们报告了首例 MSO 伴同步多发亚厘米大小甲状腺 PTC 的病例,甲状腺中含有一致的 BRAF V600E 突变,导致不一致的 LOH 发现。该数据表明,肿瘤抑制基因表达的丧失可能是恶性表型表达的重要因素。